NVN Liquidation, Inc.
NOVNDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001467154
NVN Liquidation, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 27, 2023; 33 institutions reported holding it in 13F filings for Q2 2023, worth $856.9K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by NVN Liquidation, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for NVN Liquidation, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sanders Machelle | Director | 25,248 | Jun 27, 2023 | 0 |
| Keegan Robert J | Director | 42,404 | Jun 8, 2023 | 0 |
| Bierman James L | Director | 40,101 | Jun 8, 2023 | 0 |
| Skolsky Steven D | Director | 36,101 | Jun 8, 2023 | 0 |
| Geer W Kent | Director | 37,683 | Jun 8, 2023 | 0 |
| Gay John M. | Chief Financial Officer | 46,831 | Jun 8, 2023 | 0 |
| John A. Donofrio | EVP, Chief Operating Officer | – | Jun 8, 2023 | 0 |
| Palmour John W | Director | 69,356 | Jun 9, 2022 | 0 |
| Novak Andrew | VP, Accounting and Bus Ops | – | Jun 9, 2022 | 0 |
| Stafford Paula B | President and CEO | – | Jan 25, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2022 (view filing) | Mar 16-17 | 2 days | Palmour John WDirector | PPurchase | +10.0K | $3.34 | +$33.4K | +20.3%59.4K after | 2 lots |
| Mar 22, 2022 (view filing) | Mar 18 | 4 days | Gay John M.Chief Financial Officer | PPurchase | +1.00K | $3.50 | +$3.50K | +66.7%2.50K after | |
| Mar 22, 2022 (view filing) | Mar 18 | 4 days | Palmour John WDirector | PPurchase | +10.0K | $3.64 | +$36.4K | +16.8%69.4K after | |
| Mar 28, 2022 (view filing) | Mar 25 | 3 days | Bierman James LDirector | PPurchase | +2.00K | $3.55 | +$7.10K | New position2.00K after | |
| Mar 30, 2022 (view filing) | Mar 28 | 2 days | Bierman James LDirector | PPurchase | +1.00K | $3.45 | +$3.45K | +50.0%3.00K after | |
| Apr 11, 2022 (view filing) | Apr 7 | 4 days | Bierman James LDirector | PPurchase | +1.00K | $3.45 | +$3.45K | +33.3%4.00K after | |
| Jun 27, 2023 (view filing)6:30 PM ET | Jun 27 | Same day | Sanders MachelleDirector | SSale | −11.6K | $0.4082 | −$4.72K | −31.4%25.2K after |